-+ 0.00%
-+ 0.00%
-+ 0.00%

Cyclo Therapeutics Q3 EPS $(0.31) Misses $(0.16) Estimate, Sales $233.77K Miss $294.00K Estimate

Benzinga·11/14/2024 13:38:06
Listen to the news
Cyclo Therapeutics (NASDAQ:CYTH) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.16) by 93.75 percent. This is a 6.9 percent decrease over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $233.77 thousand which missed the analyst consensus estimate of $294.00 thousand by 20.49 percent. This is a 52.82 percent decrease over sales of $495.48 thousand the same period last year.